Effect of Early Implementation of Prone Positioning
prone
1 other identifier
observational
70
1 country
1
Brief Summary
Background and objective: The ramifications of early lung protective measures and prone positioning on the ICU length of stay rates of participants admitted to the ICU with acute respiratory distress syndrome amid the COVID-19 pandemic constitute a pivotal examination. The study aims to identify the effect of early prone positioning on the length of stay, discharge rate, and number of tracheostomized patients in the ICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2022
CompletedFirst Submitted
Initial submission to the registry
February 23, 2024
CompletedFirst Posted
Study publicly available on registry
March 1, 2024
CompletedMarch 1, 2024
February 1, 2024
2.1 years
February 23, 2024
February 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of discharged patients
Number of discharged patients
26 MONTHS
Secondary Outcomes (3)
The total length of stay
26 MONTHS
ICU length of stay
26 MONTHS
Patients who underwent tracheostomy procedures
26 MONTHS
Study Arms (2)
Group A
Group A (n:39) included patients who had been early placed in prone positions within 24 hours of intubation
Group B
Group B (n:31) included patients who had not been placed in prone position
Interventions
Eligibility Criteria
A total of 124 patients were recruited initially to the study who were admitted with ARDS to the ICU. A total of 70 patients were finally included and divided into two groups,
You may qualify if:
- All patients of both sexes.
- Aged from 18 to 70 years.
- Body Mass Index (BMI) from 25 to 35 kg/m2.
- Critically ill due to ARDS resulting from COVID-19 pneumonia.
You may not qualify if:
- Patients who spent more than 24 hours on mechanical ventilators before enrolment in the study.
- Patients who died within the first 24 hours of presentation.
- Patients with advanced cancer.
- Pregnant patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zulekha Hospitalslead
- Al-Azhar Universitycollaborator
Study Sites (1)
Al-Azhar faculty of medicine
Cairo, 12546, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
SAMEH H SEYAM, PHD
Consultant critical care
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Target Duration
- 26 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2024
First Posted
March 1, 2024
Study Start
March 4, 2020
Primary Completion
April 20, 2022
Study Completion
April 20, 2022
Last Updated
March 1, 2024
Record last verified: 2024-02